NET 11 Preview 4 delivers a broad set of developer-facing updates across .NET MAUI, ASP.NET Core, Blazor, Entity Framework Core, the SDK, libraries and runtime performance work.

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Cryptocurrency ATMs also face ban, after public inquiry found Canada lacked anti-money-laundering strategy Canada is to establish a new and powerful law enforcement agency to investigate financial ...

Indian benchmark indices rallied sharply on Monday, with the Nifty surging 312.40 points, or 1.32%, to close at 24,031.70, ...

The core PCE price index, the Fed's preferred inflation gauge, accelerated a seasonally adjusted 0.3% for the month, pushing the 12-month inflation rate to 3.2%. Headline prices rose 0.7%, putting the ...

This page may contain affiliate links to legal sports betting partners. If you sign up or place a wager, FOX Sports may be compensated. Read more about Sports Betting on FOX Sports. BetMGM is one of ...

We moved away from an LLM-first approach and shifted toward a code-first architecture with bounded AI assistance.

Clinical stage company Evaxion Biotech is using artificial intelligence (AI) to simulate the immune system and create predictive models to identify novel targets for vaccines against bacterial and ...

The current DraftKings promo code offers new users $100 in bonus bets instantly after placing a $5 bet. This latest DraftKings promo can be claimed by betting on any sporting events taking place this ...

Earnings call Sandoz delivered Q1 2026 net sales of $2.8 billion, up 11% headline and 3% at constant currency, driven by 18% biosimilar growth and strong North America execution. Management reaffirmed ...

The latest BetMGM Sportsbook bonus code for new users is a welcome offer worth up to $1,500 in bonus bets if your first bet loses in May. Those interested in this promo can click CLAIM BONUS and ...

Global Phase 3, randomized, controlled trial comparing azenosertib to standard-of-care chemotherapy now enrolling ASPENOVA designed as confirmatory study to support DENALI Phase 2 accelerated approval ...